Journal of Obesity / 2024 / Article / Tab 3 / Review Article
Exploring the Prevalence and Components of Metabolic Syndrome in Sub-Saharan African Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis Table 3 Characteristics of the included studies that evaluated the prevalence of MetS among T2DM in sub-Saharan population.
Author (year) Country Study design Sampling method Survey period Sample size Sex Mean age Diagnostic criteria Overall prevalence (NCEP/ATP-III) (%) (IDF) (%) Kalk and Joffe [25 ] 2008 South Africa Cross-sectional study Convenience sampling 1994–2002 500 Both 48.3 ± 8.7 IDF — 69.0 Titty et al. [26 ] 2008 Ghana Cross-sectional study Convenience sampling January 2006 to May 2007 456 Both 55.8 ± 12.3 NCEP-ATP III 55.9 — Titty [27 ] 2009 Ghana Cross-sectional study Unspecified June 2006 to May 2007 300 Both 57.8 ± 11.3 NCEP-ATP III 60.3 — Puepet et al. [28 ] 2009 Nigeria Cross-sectional study Convenience sampling January 2006 to December 2008 634 Both 54.2 ± 9.1 IDF — 63.6 Unadike et al. [29 ] 2009 Nigeria Cross-sectional study Unspecified January to August 2008 240 Both 50.8 ± 11 NCEP-ATP III 62.5 — Chanda et al. [30 ] 2010 Zambia Cross-sectional study Unspecified Unspecified 400 Both 59.3 ± 11.13 NCEP-ATP III 73.0 — Titty [31 ] 2010 Ghana Cross-sectional study Convenience sampling September 2006 to August 2007 240 Both 47.2 ± 12.3 NCEP-ATP-III 43.3 — Ogbera et al. [32 ] 2011 Nigeria Cross-sectional study Unspecified Unspecified 201 Female 62.4 ± 7.7 NCEP-ATP III 69.0 — Kangne et al. [33 ] 2012 Cameroon Cross-sectional study Convenience sampling 2006–2008 308 Both 55.8 ± 10.5 NCEP-ATP III, IDF 60.4 71.7 Osuji et al. [34 ] 2012 Nigeria Cross-sectional study Unspecified Unspecified 93 Both 55.27 ± 12.55 NCEP-ATP III 66.7 — Mogre et al. [35 ] 2014 Ghana Cross- sectional study Convenience sampling Unspecified 200 Both 56.2 ± 12.13 IDF — 24.0 Ejiofor et al. [37 ] 2015 Nigeria Cross-sectional study Simple random sampling March to September 2006 366 Both Unspecified NCEP-ATP III 67.8 — Nsiah et al. [36 ] 2015 Ghana Cross-sectional study Unspecified February to April 2013 150 Both 51.3 ± 0.97 NCEP-ATP III 58.0 — Amoabeng Abban et al. [39 ] 2017 Ghana Cross-sectional study Convenience sampling March to April 2015 103 Both 56.24 ± 9.77 NCEP-ATP III, IDF 59.09 75.0 Amidu et al. [40 ] 2017 Ghana Cross-sectional study Convenience sampling November 2010-March 2011 274 Male 59.9 ± 11.3 NCEP-ATP III, IDF 65.3 43.1 Onyenekwu et al. [38 ] 2017 Nigeria Cross-sectional study Systematic sampling Unspecified 108 Both Unspecified IDF — 97.2 Osei-Yeboah et al. [41 ] 2017 Ghana Cross-sectional study Convenience sampling February to April 2016 162 Both 56.4 ± 10.6 NCEP-ATP III, IDF 43.8 69.1 Woyesa et al. [42 ] 2017 Ethiopia Cross-sectional study Simple random sampling February to May 2017 314 Both 49.8 ± 9.8 NCEP-ATP III 70.1 — Tadewos et al. [43 ] 2017 Ethiopia Cross-sectional study Systematic random sampling March to November 2014 270 Both 48.8 ± 11.9 NCEP-ATP III 45.9 — Biadgo et al. [44 ] 2018 Ethiopia Cross-sectional study Unspecified June to July 2015 159 Both 49.8 ± 8.7 NCEP-ATP III, IDF 66.7 53.5 Birarra and Gelayee [45 ] 2018 Ethiopia Cross-sectional study Systematic random sampling March to May 2017 256 Both Unspecified NCEP-ATP III, IDF 70.3 57.0 Obirikorang et al. [46 ] 2018 Ghana Cross-sectional study Nonprobability convenience sampling Unspecified 384 Both 56.4 ± 13.1 NCEP-ATP III, IDF 77.1 76.3 Agyemang-Yeboah et al. [47 ] 2019 Ghana Cross-sectional study Simple random sampling Unspecified 405 Both 58.5 ± 9.9 NCEP-ATP III 90.6 — Gebremeskel et al. [48 ] 2019 Ethiopia Cross-sectional study Simple random sampling February to June 2018 419 Both 56.39 ± 10.18 IDF — 51.1 Bizuayehu Wube et al. [49 ] 2019 Ethiopia Cross-sectional Simple random sampling February to May 2017 314 Both 49.8 ± 9.8 NCEP-ATP III, IDF 70.1 52.9 Zerga and Bezabih [50 ] 2020 Ethiopia Cross-sectional study Simple random sampling February to March 2017 330 Both Unspecified NCEP-ATP III, IDF 59.4 50.3 Anto et al. [51 ] 2022 Ghana Cross-sectional study Convenience sampling March to June 2021 241 Both Unspecified NCEP-ATP III 42.7 — Gebreyesus et al. [52 ] 2022 Ethiopia Cross-sectional study Systematic sampling September to November 2019 421 Both 58.2 ± 11 NCEP-ATP III, IDF 67.9 57.0 Gemeda et al. [53 ] 2022 Ethiopia Cross-sectional study Simple random sampling September 2020 to August 2021 394 Both Unspecified NCEP-ATP III 68.3 — Charkos and Getnet [54 ] 2023 Ethiopia Cross-sectional study Systematic random sampling September to October 2022 237 Both Unspecified NCEP-ATP III, IDF 41.3 41.8
IDF: International Diabetes Federation; NCEP-ATP-III: National Cholesterol Education Program-Adult Treatment Panel I.
